genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
    • Trends for 2023
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
    • Lung Cancer
      Cancer

      Changing Carcinogenic Cells in the Lungs with Novel Technology

      Human microbiome
      Gastrointestinal Disorders

      GI GVHD Link to Microbiome Dysbiosis Addressed by Reducing Intestinal Oxygen

      Cancer

      Molecular Anchor Creates More Effective CAR T Immunotherapies

      White House
      Cancer

      White House Continues Dedication to “End Cancer as We Know It”

      Cancer Cells
      Cancer

      Molecular Pathways Used by Metastatic Cancer Cells Uncovered

  • Insights
    • AllTrends for 2020Trends for 2021Trends for 2023
      Spatial Biology

      Spatial Biology Current State of the Art and What’s Coming Next

      Joseph M. Beechem
      Spatial Biology

      GEN Interview with Joseph M. Beechem, PhD, Chief Scientific Officer of…

      SMI Raw Data
      Spatial Biology

      Choosing the Right Spatial Technology

      CosMx SMI image
      Spatial Biology

      Spatial and NGS Dominate Proceedings at AGBT 2022

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • Hand Shake Meetings
      Drug Discovery

      Seven Biopharma Trends to Watch in 2023

      NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      stocks go up
      A-Lists

      Top 25 Biotech Companies of 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Home Therapeutics Enzyme Replacement Therapy

Enzyme Replacement Therapy

  • Anti-Ulcerants
  • Antibacterials
  • Antibiotics
  • Anticoagulants
  • Antidiabetics
  • Antifungals
  • Antivirals
  • Autoimmune Disease Drugs
  • Biologics
  • Biosimilars
  • Cardiovascular Drugs
  • Cellular Therapeutics
  • Combination Therapies
  • Dermatologic Drugs
  • Enzyme Replacement Therapy
  • Generics
  • Hormone Replacement Therapy
  • Immuno-oncology
  • Immunotherapies
  • Lipid Regulators
  • Mental Health Drugs
  • Oncologics
  • Orphan Drugs
  • Pain
  • Protein Therapeutics
  • Psychoactive Drugs
  • Radiopharmaceuticals
  • Respiratory Drugs
  • Traditional Chinese Medications
  • Vaccines
    Latest
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    Enzyme Replacement Therapy

    Rubius Therapeutics Closes $120M Financing, Plans Trials Next Year

    Enzyme Replacement Therapy

    Alexion to Eliminate 7% of Workforce

    Enzyme Replacement Therapy

    Amicus Cuts Jobs, Overhauls GSK Collab, and Acquires Callidus

    Enzyme Replacement Therapy

    Lonza to Manufacture Heart Failure Enzyme Replacement Therapy

    Enzyme Replacement Therapy

    Genzyme Gets FDA, EMA Approvals for Production Plant in Waterford, Ireland

    Enzyme Replacement Therapy

    Protalix, Pfizer Report FDA Approval of Plant-Derived Gaucher Disease ERT Elelyso

    Enzyme Replacement Therapy

    EMA Green-Lights Shire’s Manufacturing Site in Lexington, MA, for Gaucher Therapy

    Enzyme Replacement Therapy

    Alexion Pays $610M to Buy Enobia for Hypophosphatasia ERT Candidate

    Enzyme Replacement Therapy

    Oxyrane Raises $26.5M to Take Lead Enzyme Replacement Therapy Through Phase...

    Enzyme Replacement Therapy

    Enobia Raises $40M to Further Develop Phase II-Stage ERT for Hypophosphatasia

    The new entity will be publicly traded and will focus on orphan drugs. [© Sergey Ilin - Fotolia.com]
    Enzyme Replacement Therapy

    Synageva Merges with Trimeris in All-Stock Deal

    Enzyme Replacement Therapy

    Halozyme and Intrexon to Develop Subcutaneous Recombinant Alpha 1-Antitrypsin Replacement Therapy

    Funds will be used to continue clinical development of lead LAL deficiency enzyme replacement therapy.[© Bobby4237 - Fotolia.com]
    Enzyme Replacement Therapy

    Synageva Raises $25M Through Private Placement with Existing Investors

    Enzyme Replacement Therapy

    Enobia Chooses Lonza for Commercial-Scale Manufacture of Its Enzyme-Replacement Therapy

    Pharmacological chaperone is designed to stabilize a-GAL A and restore its activity.[Sergey Ilin-Fotolia.com]
    Enzyme Replacement Therapy

    GSK Pays Amicus $30M Up Front for Phase III Fabry Disease...

    12Page 1 of 2

    Recently Featured

    Spatial Biology Current State of the Art and What’s Coming Next

    Spatial Biology Current State of the Art and What’s Coming Next

    <i>GEN</i> Interview with Joseph M. Beechem, PhD, Chief Scientific Officer of NanoString Technologies

    GEN Interview with Joseph M. Beechem, PhD, Chief Scientific Officer of NanoString Technologies

    Spatial and NGS Dominate Proceedings at AGBT 2022

    Spatial and NGS Dominate Proceedings at AGBT 2022

    Spatial Technology Offers Spectacular Insights

    Spatial Technology Offers Spectacular Insights

    Read the Digital Edition

    GEN February 2023 cover

    Explore

    • About GEN
    • Contact GEN
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • Inside Precision Medicine
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up